Clinical Trial Update: Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study [Phase 2]

View source ↗

Summary

Phase 2 trial (COVER-ALL) evaluating Morfeus software‑aided imaging to confirm tumor coverage during ablation in patients with malignant liver neoplasms. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Liver Neoplasm | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-11-21